Maintaining healthy habits, such as a balanced diet and regular exercise, is key to keeping weight off after stopping GLP-1 treatment
New research presented on October 8, 2025, at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM25) held in Barcelona, Spain, shows that these drugs can produce atypical tracer uptake patterns that may mimic malignancy or inflammatory disease
However, the analysis of the gut microbiota using NGS after a single administration of GLP-1RA has not been studied, and this is a subject for further study
People deserve clear safety data, real efficacy trials, and honest language before a compound gets treated like legitimate medicine
At present, the prevailing GHK-Cu dosage protocol appears to be as follows: Daily Dosage: 1-2 mg of GHK-Cu